You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address